Today, on #ScienceAppreciationDay, we celebrate the curiosity, innovation, and dedication that drive scientific discovery forward. At #AskBio, we’re especially grateful for our incredible researchers who work to advance life-changing therapeutics and bring hope to patients around the world. On this day in 1953, Dr. Jonas Salk announced the successful development of the polio vaccine—an achievement that saved lives and changed the course of medicine. His legacy reminds us of the transformative power of science, and we’re proud to carry that spirit forward every day. Here’s to the scientists—past, present, and future—who continue to shape a healthier tomorrow.
AskBio Inc.
Biotechnology Research
Research Triangle Park, North Carolina 39,244 followers
About us
AskBio Inc., a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for congestive heart failure, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s gene therapy platform includes Pro10™, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter library. With global headquarters in Research Triangle Park, North Carolina, and European headquarters in Edinburgh, Scotland, the company has generated hundreds of proprietary capsids and promoters, several of which have entered pre-clinical and clinical testing. Learn more at askbio.com. Vision - Pioneering science to create transformative molecular medicines. Mission - Lead innovative science and drive clinical outcomes to transform people's lives. Values: • Be a Pioneer. We are not afraid of the impossible and to innovate to make gene therapies accessible to those in need. • Cultivate Collaboration. Strive to be the best teammate, actively listen, openly communicate, and embrace diverse points of view. • Embrace Responsibility. We are humbled by the enormity of our mission. We hold a relentless commitment to advance science and clinical outcomes for our patients, families, and caregivers. • Raise the Bar. Continuously drive improvements and efficiencies. Seek and provide constructive feedback. Have a bias for learning and action. • Act with Uncompromising Integrity. Be honest, transparent, and committed to doing what’s right in every situation. Make clear commitments and follow through.
- Website
-
http://www.askbio.com
External link for AskBio Inc.
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Research Triangle Park, North Carolina
- Type
- Privately Held
- Specialties
- AAV, Adeno-Associated Virus, Gene Therapy, Rare Disease, AAV Manufacturing, Molecular Medicine, Nucleic Acid, Epigenome, and Doggybone DNA
Locations
Employees at AskBio Inc.
-
Gustavo Pesquin
-
Doug Schantz
Senior Vice President of Clinical Operations at Asklepios BioPharmaceutical, Inc. (AskBio)
-
Kira Mourão MBCS
Principal Machine Learning Scientist at Asklepios BioPharmaceutical, Inc. - (AskBio)
-
Kara Witcoff
Patient Advocacy & External Engagement / Public Affairs / Strategic Alliances / Business Development / Global Relations
Updates
-
Learn more about the past, present, and future of gene therapy in #HeartFailure. Mark your calendar and join us for lunch and an engaging Industry Expert Theater session at #ACC25 in the Expo Hall, Theater 1, Expo 16077! Gain fresh insights into #CardiovascularHealth from speakers Roger Hajjar, MD; Tim Henry, MD, FACC, MSCAI; JoAnn Lindenfeld, MD, FHSA; and Javed Butler, MD. Explore expert perspectives on AAV gene therapy, featuring updates from the GenePHIT Phase 2 trial of AB-1002. Check out the agenda for ACC.25! ➡️ https://bit.ly/41masXp #GeneTherapy #CHF #ClinicalTrials
-
Our Talent Acquisition team has been busy connecting with passionate students and future innovators at career fairs across Duke University, University of North Carolina at Chapel Hill, North Carolina State University, North Carolina Central University, and University of Pennsylvania. We’re inspired by the next generation of talent and proud to share the mission of #AskBio with those who are eager to shape the future of genetic medicine. Thank you to all the students we met. We enjoyed speaking with you and appreciate your stopping by, asking thoughtful questions, and exploring where your careers could take you with AskBio. For those we haven’t yet met, if you’re driven to push at the boundaries of what’s possible, bring transformative therapeutics to patients in need, and grow in an environment that’s conducive to reaching your full potential, explore our open opportunities: https://lnkd.in/gkpPZ6at #CareerFairs #BiotechCareers #GeneTherapy Amanda Carson, William Hinton, KaCie Willis, Asia J. Y., James Aykit, Amanda Peterson, Blake Rust, Deanna Sedlak, Kayla Shumate, PhD, Joe Fulbright, Blanca López de Juan Abad, Liang Zhou, D'Shawna Burwell
-
This #MSAAwarenessMonth, our hearts are with the patients, families, and caregivers affected by this rare and devastating disease. 💜 At #AskBio, we’re helping shine a light on the powerful work of Mission MSA and DEFEAT MSA ALLIANCE (USA)—organizations offering hope and support to caregivers, healthcare professionals, and those living with MSA. To learn more about MSA and what we can all do to stand in solidarity with the MSA community, please visit the websites of these two amazing organizations: 🔗 https://missionmsa.org/ 🔗 https://defeatmsa.org/
-
Saturday marked International Women's Day, a powerful reminder of the incredible contributions of women worldwide. As we carry that spirit forward, we're thrilled to share that tomorrow our Women's Leadership Initiative (WLI) Employee Resource Group (ERG) is hosting a fireside chat on gender equity in the workplace. This event is especially meaningful for us, because women make up over 50% of the #AskBio team and are essential in our effort to drive scientific breakthroughs. Whether they are pioneering research in gene therapy, leading our clinical trials, or serving on our Board, women at AskBio are making a tangible difference in all we do to hopefully improve the lives of patients living with some of the world’s most devastating diseases. Let's continue to celebrate and empower women in science and leadership! #InternationalWomensDay #WLI #WomenInScience #GeneTherapy Albana Alili Dalipi, Stacy W., Deb Cole, Waldy San Sebastian, Claire My Dung TRAN, Meg Heim, Tracy Dowling
-
Limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9) is a rare disease and there is currently no treatment that modifies disease progression. #AskBio is dedicated to harnessing the potential of gene therapy to provide improved treatment options for LGMD2I/R9 worldwide. A critical component of this work is the advancement of our Phase 1/2 LION-CS101 clinical trial in the US, which is currently enrolling. For Medical Media – Read our press release here: https://lnkd.in/efQVDqYK #GeneTherapy #LGMD #RareDisease Blair Robertson, John Jameson, Kenneth Miller, Sam Hopkins, Steven Elmes
-
-
February was a month of dual celebrations at #AskBio! We embraced the opportunity to champion Black history and heart health with a variety of events. Our celebrations included a Black History Month kick-off and trivia game, organized by our African American Employee Resource Group (AA ERG), along with the “Day in the Life of an AA ERG Member” panel discussion; insightful discussions with Bayer on clinical trial diversity; and a virtual conversation on diversity, equity, and inclusion. We also promoted heart health awareness with initiatives like National Wear Red Day; benefitted from hands-free CPR training led by the American Heart Association; and provided healthy snack options for our teams in North Carolina, Philadelphia, Ohio, Heidelberg (Germany), Paris (France), and Edinburgh (Scotland). An AA ERG-sponsored cupcake celebration provided a sweet ending to a month packed with learning. We're proud of our employee-organized activities and remain dedicated to fostering a culture where every voice is heard and valued, and where employee health and well-being are prioritized. #BlackHistoryMonth #HeartMonth #GeneTherapy Julius C. Graham, Doug Schantz, Melissa Murrell, William Hinton, Caitlin Taroski, Asia J. Y., Dylo Lisa Ratliff, MCPC, Gaelle M., Kevin Webster, Amanda Carson, Delicia Bryant, Blanca López de Juan Abad, Dexter Emery, Kavonne Brooks, Irene G., Youjun Chen, Larissa Benavente, Ronna Dornsife, M.S.; Blake Rust, Cassandra Simone, Nadja Hunter, MBA; Shari Gordon, Kim Clarke, Meg Heim, Eisha S. C., Jenny Siferd, SPHR, Emily Slocumb, Horace Rozier, Ellen Kelly, Heather Caro, CA-AM, Pooja Merchant, Kara Witcoff, Santosh Sanganalmath MD, PhD, FACC; Ilaria Montalbano, Farah CHALI, Lesley Flood, Rosheen Caw, Stacey L. Abby, Pharm.D., Mary Shaffer
-
Happy to have the opportunity to sponsor this important event being organized by The Speak Foundation and CureLGMD2i Foundation. #LGMD2I/R9 #GeneTherapy
The Speak Foundation and Cure LGMD 2i personally invite you to an exclusive and enlightening webinar on March 26th at 3pm ET featuring Dr. Nicholas Johnson with Virginia Commonwealth University. We will explore the potential of gene therapy in treating Limb-Girdle Muscular Dystrophy (LGMD 2I/R9). Register today at https://lnkd.in/ggGnGGgG. During this engaging session, Dr. Johnson will share insights into AskBio's ongoing LGMD2I/R9 clinical study (LION-CS101) and discuss the potential impact of gene therapy treatment now and in the future. Don't miss this unique opportunity to deepen your understanding of the science behind gene therapy and hear directly from a leading expert at the forefront of innovative treatments. Q and A will also follow the webinar with Kelly Brazzo from Cure LGMD 2i hosting along with Kat Bryant Knudson from the Speak Foundation. #LGMD #clinicaltrials #LGMD2i #Genetherapy
-
-
Rare Disease Day (RDD) is a reminder of the urgent need for scientific progress. On Tuesday, we held our own internal event to recognize the importance of this day. Today, we were proud to join Viralgen, our subsidiary, as they brought together #AskBio, Bayer, Fundación Columbus, CTNNB1 Foundation, Broad Institute of MIT and Harvard, and Cytiva to collectively support rare diseases. Bringing together companies, foundations, academics, and others to broaden the RDD discussion was a powerful and inspiring way to mark this important day. At #AskBio and Viralgen we believe that the complexity of rare disease demands a forward-looking approach, combining pioneering science with advanced clinical translation and manufacturing technology. We're committed to working together to find solutions and improve lives. #RareDiseaseDay #Viralgen #GeneTherapy Bayer | Pharmaceuticals, Jordi Sanchez, Špela Miroševič, Tracy Dowling, Sonia Vallabh, Claudia Gagliardini, Javier Garcia, Jimmy V., Andy Holt, Cesar Trigueros, Philippe Moullier, Melissa Murrell
-
As we approach March 1 and the start of #MSAAwarenessMonth, we had the privilege earlier this week to hear from Mike, who lives with the disease, and his wife and caregiver Colleen. The couple joined us for our annual Rare Disease Day event and shared their powerful story. Mike underscored the challenges faced by so many in the multiple system atrophy community. His symptoms began in 2010, but it wasn't until 2020 that he received his diagnosis. Throughout that period, MSA limited Mike's ability to work and live his daily life. He mentioned that he went from being a rocket scientist and accomplished academic, to no longer being able to balance his checkbook. He faces frequent fainting spells, impacting his mobility and independence. He poignantly described the shrinking of his world and the difficulty of everyday tasks. "This is a real disease and it really does require so many different treatments because there are so many different pieces of Mike's functioning that are impacted," Colleen said. "I take medication currently for almost every autonomic function my body has," Mike stated. While the diagnosis provided a name to his condition, it also brought the stark reality of its progression. Yet, Mike's spirit remains strong, and the unwavering support of his wife, Colleen, is truly inspiring. As we look ahead to MSA Awareness Month, Mike's story reminds us of the importance of raising awareness, supporting research, and advocating for those living with this rare and debilitating disease. During the month ahead, Mike, Colleen, and the many others in the MSA community will be in our thoughts, reminding us of the urgency and importance of our work. #MSAAwarenessMonth #MSAawareness #RareDiseaseDay